In an animal model of asthma, increased TGF‐β1 expression and bronchial/peribronchial ASM growth occur concurrently, and the use of drugs targeting TGF‐β can prevent or reverse airway remodelling.29 This evidence concerns the gene TGFB1 and asthma.